Screener
Lexicon Pharmaceuticals LXRX Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Stock-based compensation | 6,414 | 6,238 |
| Amortization of debt-related costs | 1,213 | 803 |
| Loss on early extinguishment of debt | 4,349 | — |
| Accretion of marketable securities purchased at a discount | (1,292) | (2,540) |
| Other non-cash adjustments | (99) | (1,561) |
| Changes in operating assets and liabilities: | ||
| Decrease in accounts receivable, net | 741 | 1,290 |
| (Increase) decrease in inventories | (915) | 63 |
Item 1. Financial Statements
FAQ
- What is Lexicon Pharmaceuticals's accretion (amortization) of discounts and premiums, investments?
- Lexicon Pharmaceuticals (LXRX) reported accretion (amortization) of discounts and premiums, investments of $730K in Q2 2026.
- How has Lexicon Pharmaceuticals's accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Lexicon Pharmaceuticals's accretion (amortization) of discounts and premiums, investments decreased by 39.9% year-over-year, from $1.21M to $730K.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This represents the non-cash adjustment to net income for the amortization of premiums or the accretion of discounts on investment securities held by the company. It reflects the systematic recognition of the difference between the purchase price and the par value of debt securities over their remaining term. This adjustment is essential for reconciling net income to cash flow from operations by removing the impact of these non-cash yield adjustments.
Ask your AI about Lexicon Pharmaceuticals's accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude